NATCO PHARMA LTD. - Outcome of Board Meeting (EGM on June 27, 2015)
| < Back | |
| 22 May 2015 | |
| Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 22, 2015, inter alia, ha approved and taken on record the following:<BR><BR>1. Increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc.<BR><BR>2. Further issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional Placement (QIP) to Foreign Institutional Investors (FIIs), Qualified Institutional Buyers or any other investors etc. up to an amount of Rs. 450 crores (Rupees four hundred and fifty crores only).<BR><BR>3. Merger of Natco Organics Limited (100% subsidiary Company) into Natco Pharma Limited.<BR><BR>4. Issue of Employee Stock Options not exceeding 1,50,000 equity shares of Rs. 10/- (Rupees ten only) each under SEBI (Share Based Employee Benefits) Regulations, 2014.<BR><BR>5. Implementation of new code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015.<BR><BR>6. To Convene Extraordinary General Meeting of the Members of the Company on June 27, 2015. | |
| View all announcements for NATCO PHARMA LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback